Niche London has advised Ipes (UK) Ltd on its expansion-led UK office headquarters relocation from Victoria to the City. Ipes, a provider of outsourced services to the European Private Equity market, has moved from its offices in London’s Victoria, to new premises in the City of London.   McCalmont-Woods Ipes advised Ipes on the move to 8,100 sq ft of accommodation on the 9th floor of 1 Minster Court, EC3. A new 10-year lease has been agreed on the newly refurbished landmark building with the landlord, Prudential Assurance, advised by CBRE and Spring4.   Ipes currently provides administration and depository

Morgenthaler Private Equity (MPE) has recapitalised Trachte, a manufacturer of preassembled and modularised control buildings.  The company's custom buildings house critical electrical components that control and protect electrical infrastructure, such as transmission & distribution substations.  In addition, Trachte buildings are used extensively in industrial applications to house equipment, such as switchgear, motor controls, and pumps. Trachte serves utilities, OEMs, and other channel partners in the power generation, energy, chemical processing, data centre, and general industrial end markets.   MPE partnered in the transaction with the existing shareholders, including retiring President Randy Trachte and retiring VP of Sales Ron Trachte, as well

Arma Partners has acted as exclusive financial advisor to IRIS Software Group Limited on its recapitalisation by HgCapital at an enterprise valuation of GBP763 million. HgCapital has been an investor in IRIS Software since acquiring the business for GBP102 million in 2004 and a majority owner for seven of the past eleven years.     With 35 years’ experience, IRIS Software is a leading provider of business critical software and services to the UK accountancy and SME sectors. Over 18,000 UK accountancy firms use IRIS Software every day to run their practices, with 7,000 consuming at least one cloud solution

Private equity firm Mid Europa Partners is to take full ownership of Walmark after agreeing to buy out the founding Walach family. The transaction is subject to anti-trust clearance. Mid Europa originally acquired a 50 per cent stake in the consumer healthcare company in December 2012.   Michelle Capiod (pictured), Partner at Mid Europa, says: "We would like to thank the Walach family for our excellent partnership and wish them great success in their future endeavours. We have jointly transformed Walmark from the leading dietary supplements business in Central and Eastern Europe into a focused consumer healthcare platform with an

Inflexion has completed the GBP92m buyout of Alcumus Group Ltd (Alcumus), a market-leading provider of technology-enabled compliance risk management and certification services, from Sovereign Capital. Alcumus serves over 8,000 clients, including 35 per cent of the FTSE 100, providing outsourced risk management services which are critical to compliance with UK regulations and internationally recognised standards. Formed through the integration of five companies, this high growth business holds a prominent share of the fragmented UK market, valued at around GBP500m and forecast to grow by up to 10 per cent per annum. Favourable market conditions are driven by a continuous regulatory

This factsheet from Preqin brings you up to speed with the latest data and information on private equity backed deals and exits that took place in Q3 2015. The factsheet features top-level industry statistics, key takeaways and listings of the largest deals and exits to have occurred in the third quarter.  View the factsheet here.

The Edmond de Rothschild is looking to bolster its private equity offer, with the objective of increasing assets under management by more than 50 per cent over the next two years. As part of this strengthened commitment to private equity, the Group is launching ERES III, a new fund dedicated to global growth strategies, in the coming weeks. The Group’s ambition is to raise EUR250-300 million, compared to a total of EUR320 million raised for ERES I and ERES II.   Additional funds currently being raised, including China 2, Ginko 22 and TIIC 22. Other fund-raisings in the Cabestan, BioDiscovery